Active Ingredient History
Maltodextrin is a name shared by two different families of chemicals. Both families are glucose polymers, but have little chemical or nutritional similarity. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 3)
Anxiety (Phase 2)
Arthroplasty, Replacement, Knee (Early Phase 1)
beta-Thalassemia (Phase 3)
Binge Drinking (Phase 2)
Bone Diseases (Phase 1)
Bone Diseases, Endocrine (Early Phase 1)
Carbohydrates (Early Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Cardiovascular Diseases (Phase 2)
Central Serous Chorioretinopathy (Phase 2/Phase 3)
Colitis, Ulcerative (Early Phase 1)
Constipation (Phase 4)
COVID-19 (Phase 2/Phase 3)
Critical Illness (Phase 3)
Crohn Disease (Early Phase 1)
Depressive Disorder, Major (Phase 2)
Dermatitis, Atopic (Phase 3)
Diabetes Mellitus, Type 1 (Phase 1)
Diarrhea (Phase 2)
Diet Therapy (Phase 2)
Dyspepsia (Phase 1/Phase 2)
Endothelial Cells (Phase 2)
Enteral Nutrition (Phase 3)
Enteritis (Phase 3)
Fatigue (Phase 2)
Fibrosis (Phase 2)
Gastrointestinal Microbiome (Phase 2)
General Surgery (Phase 3)
Geriatrics (Early Phase 1)
Healthy Volunteers (Phase 4)
Heart Failure (Phase 1)
Hepatic Encephalopathy (Phase 4)
Infections (Phase 3)
Inflammation (Phase 4)
Insulin Resistance (Phase 3)
Intensive Care Units (Phase 2)
Intestinal Neoplasms (Phase 3)
Irritable Bowel Syndrome (Phase 3)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 4)
Liver Failure (Phase 2)
Metabolic Syndrome (Phase 1)
Mitochondrial Diseases (Phase 2)
Multiple Organ Failure (Phase 3)
Multiple Sclerosis (Phase 2)
Neonatal Sepsis (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Nutritional and Metabolic Diseases (Early Phase 1)
Obesity (Phase 2)
Overweight (Early Phase 1)
Pain (Phase 2)
Parkinson Disease (Phase 2)
Pediatric Obesity (Phase 3)
Postoperative Complications (Early Phase 1)
Pouchitis (Phase 1)
Prediabetic State (Phase 1)
Proctitis (Phase 3)
Prostatic Neoplasms (Phase 2/Phase 3)
Quality of Life (Phase 1)
Renal Insufficiency, Chronic (Phase 2)
Respiratory Aspiration (Phase 2)
Sarcopenia (Phase 2)
SARS-CoV-2 (Phase 2)
Sepsis (Phase 2)
Signs and Symptoms, Digestive (Phase 1/Phase 2)
Steatitis (Phase 1)
Stomach Neoplasms (Phase 3)
Typhoid Fever (Early Phase 1)
Vaccines (Early Phase 1)
Ventricular Dysfunction, Left (Phase 4)
Ventricular Dysfunction, Right (Phase 4)
Vitamin D Deficiency (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue